Legal and financial questions of Pfizer-Novo-Metsera
Shareholder Primacy
00:00
What Happens Next: Closing and Future Litigation Risks
Hosts note the expected closing date, Pfizer’s entry into GLP‑1 space, and potential CVR and earn‑out litigation ahead.
Play episode from 34:21
Transcript
